top of page

Not everyone responds to medications

BioCorteX will change this by leveraging the relationship between bacteria and medications

We are developing the world's first clinically validated, knowledge-driven, human-microbiome platform that we will use to develop our own therapeutic pipeline. 

BioCorteX is a 'techbio' that applies deep technology to deliver effective therapeutics by leveraging the synergy between health and bacteria, viruses, and fungi. 


We exist because current drug development fails individuals by ignoring the (un)desirable drug-microbiome interactions.


Our key product, CarbonMirror™ uses deep tech and AI to simulate how the colossal number of microbiota interact with therapeutics, de-risking (pre-)clinical trials and replacing uncertainty with confidence for the patient. 

CarbonMirror™ technology can be applied to medications, cosmetics, personal care, manufacturing, and agriculture.

bottom of page